Most Recent
Agricultural supply company Tama has lost a lawsuit accusing cotton-harvesting products importer Parterra and distributor Cotton Growers Services of breaching its patent for cotton bale wrapping products.
Janssen has granted Biocon a licence for a biosimilar of Crohn's disease drug Stelara, following setbacks in patent proceedings with South Korean drug maker Samsung Bioepis over the drug.
A chemical engineer who helped develop patented technology to prevent pollution from fracking operations has failed in his bid to be bought out by the company for $1.43 million, with a judge rejecting his claims of shareholder oppression.
Cancer drug maker AdvanCell is seeking to block two patent applications by Norwegian biotech Sciencons AS for technology used in targeted radiation treatments for cancer.
In the latest ruling on computer-implemented inventions, an IP Australia delegate has shot down fintech Kyro Card's bid to patent a payment system for offering rewards to shoppers, finding the invention was a business scheme implemented on a computer and not a manner of manufacture.
Japanese pharmaceutical company Astellas Pharma has signed a deal worth up to $2 billion with Melbourne-based start-up Audax Biosciences to secure future rights to develop and commercialise its new cancer treatment.
Swiss pharmaceutical company Actelion has brought a fourth patent infringement case over plans to launch a generic version of its blood pressure drug in Australia -- against Lupin unit Generic Health -- after firing off cases against three other drug makers.
Engineering group Sandvik Mining and Construction has prevailed in defence of a patent application for rotary drill technology used for underground mining.
The CSIRO has lost its fight against Israeli ag-tech and biotech company eggXYt’s bid to amend its pending patent application for technology that claims to determine the gender of avian embryos, as the agency continues to oppose the patent's registration.
Indian generics giant Sun Pharmaceutical has offered to grant Ferring Pharmaceuticals a licence to sell a generic version of its IVF drug to win ACCC approval for its $16.7 billion takeover of US-based Organon.